LL-37 vs. Thymosin Alpha-1
Head-to-head comparison based on the profiles in the PepCycle library.
| Attribute | LL-37 | Thymosin Alpha-1 |
|---|---|---|
| Class | Antimicrobial | Immune Modulation |
| Description | The only human cathelicidin antimicrobial peptide, providing broad-spectrum antimicrobial activity and immunomodulatory effects. | A 28-amino acid peptide that enhances immune function by stimulating T-cell maturation and modulating cytokine production. |
| Dose in studies | 50-100 mcg per day | 1.6-3.2 mg 2-3x weekly |
| Frequency | Daily during infection/healing | 2-3x weekly |
| Half-life | 15-30 minutes | 2-3 hours |
| Cycle length | Until infection resolved, typically 1-2 weeks | 4-12 weeks based on indication |
| Research level | 2/5 – Limited research | 4/5 – Well researched |
LL-37: full profile · Thymosin Alpha-1: full profile
Values from research literature – not medical advice.